Abstract
Sjögren’s syndrome is defined as a chronic inflammatory autoimmune disorder primarily affecting the lacrimal and salivary exocrine glands. However, the disorder has also been associated with numerous extraglandular manifestations affecting such diverse tissues as the cardiovascular, central nervous, and renal systems.1 Diagnostic criteria include oral and/or ocular dryness, focal lymphocytic infiltrates in the exocrine tissues, and the presence of autoantibodies in patient sera, particularly against the nuclear factors SSA/Ro and SS-B/La. Due to inconsistencies in the various diagnostic scales, evaluation of disease prevalence worldwide is difficult and complicated further by the chronic and inconsistent nature of the symptoms in patients. 1.2
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R.I. Fox, T.J. Tornwall, T. Maruyami, and M. Stern. Sjögren’s syndrome: Evolving concepts of diagnosis, pathogenesis and therapy. Curr Op Rheum 10:446(1998).
P.C. Fox and P.M. Speight. Current concepts of autoimmune exocrinopathy: immunologic mechanisms in the salivary pathology of Sjögren’s syndrome. Crit Rev Oral Biol Med. 7:144(1996).
R.W. Hoffman, M.A. Alspaugh, K.S. Waggie, J.B. Durham, and S.E. Walker. Sjögren’s syndrome in MRL/1 and MRL/n mice. Arthritis Rheum. 27:157(1984).
N. Haneji, H. Hamano, K. Yanagi, and Y. Hayashi,. A new animal model for primary Sjögren’s syndrome in NFS/sld mutant mice. J Immunol. 153:2769(1994).
M.G. Humphreys-Beher, Y. Hu, Y. Nagakawa, P.-L. Wang, and K.R. Purushotham. Utilization of the NOD mouse as a model for the study of secondary Sjögren’s syndrome.Adv Exp Med Biol.1994;350:631–637.
C.P. Robinson, S. Yamachika, D.I. Bounous, J. Brayer, R. Jonsson, R. Holmdahl, A.B. Peck, and M.G. Humphreys-Beher. A novel NOD-derived murine model of primary Sjögren’s syndrome. Arthritis Rheum. 41:150(1998).
J. Brayer, J. Lowry, S. Cha, C.P. Robinson, A.B. Peck, and M.G. Humphreys-Beher. Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren’s syndrome-like autoimmune exocrinopathy. J Rheum. 27:1896(2000).
M. Nishihara, M. Terada, J. Kamogawa, Y. Ohashi, S. Mori, S. Nakatsuru, Y. Nakamura, and M. Nose. Genetic basis of autoimmune sialadenitis in MRL/lpr lupus-prone mice-additive and hierarchical properties of polygenic inheritance. Arthritis Rheum. 42:2616(1999).
H.J. Garchon, P. Bedossa, L. Eloy, and J.F. Bach. Identification and localization on chromosome 1 of a gene controlling the occurrence of periinsulitis in NOD diabetic mice. C-R-Acad-Sci-III. 312:377(1991).
L. Kong, C.P. Robinson, A.B. Peck, N. Vela-Roch, K.M. Sakata, H. Dang, N. Talai, and M.G. Humphreys-Beher. Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice. Clin Exp Rheumatol. 16:675(1998).
R. Masago, S. Aiba-Masago, N. Talal, F. Jiminez Zuluaga, I. Al-Hashimi, M. Moody, C.A. Lau, M.G. Humphreys-Beher, and H. Dang,. Elevated levels of bax and caspase-3 activation in theNOD-scidmodel of Sjögren’s syndrome. Arthritis Rheum. 44:693(2001)..
D.A. Sullivan, H. Ariga, A.C. Vendramini, F.J. Rocha, M. Ono, and E.H. Sato. Androgen-induced suppression of autoimmune disease in lacrimal glands of mouse models of Sjögren’s syndrome. Adv Exp Med Biol. 350:683(1994).
R.E. Hunger, C. Carnaud, I. Vogt, and C. Mueller. Male gonadal environment paradoxically promotes dacryoadenitis in nonobese diabetic mice. J Clin Invest. 101:1300(1998).
I. Toda, B.D. Sullivan, L.A. Wickham, and D.A. Sullivan. Gender-and androgen-related influence on the expression of proto-oncogene and apoptotic factor mRNAs in lacrimal glands of autoimmune and non-autoimmune mice. J Steroid Biochem Mol Biol. 71:49(1999).
R.I. Fox, T.C. Adamson, S. Fong, C. Young, and F.V. Howell. Characterization of the phenotype and function of lymphocytes infiltrating the salivary gland in patients with primary Sjögren’s syndrome. Diagn Immunol. 1:233(1983).
C.P. Robinson, J. Cornelius, D.E. Bounous, H. Yamamoto, M.G. Humphreys-Beher, and A.B. Peck. Characterization of the changing lymphocyte populations and cytokine expression in the exocrine tissues of autoimmune NOD mice. Autoimmunity. 27:29(1998).
S.C.A. van Bloldand, C.G. van Heiden-Meeuwsen, A.F. Wierenga-Wolf, H.A. Drexhage, H. Hooijkaas, J.P. van de Merwe, and M.A. Versnel. Two different types of sialoadenitis in the NOD- and MRLfIpr mouse models for Sjögren’s syndrome: A differential role for dendritic cells in the initiation of sialoadenitis? Lab Invest. 80:575(2000).
M. Boumba, F.N. Skopouli, and H.M. Moutsopoulos. Cytokine mRNA expression from patients with primary Sjögren’s syndrome. Brit J Rheum. 24:326(1995).
H. Hamano, N. Haneji, K. Yanagi, N. Ishimaru, and Y. Hayashi. Expression of HLA-DR and cytokine genes on interferon-gamma-stimulated human salivary gland cell line. Pathobiology. 64:255(1996).
O.G. Pankewycz, J.X. Guan, and J.F. Benedict. Cytokines as mediators of autoimmune diabetes and diabetic complications. Endocr Rev. 16:164(1995).
C.P. Robinson, J. Brayer, S. Yamachika, T. Esch, A.B. Peck, C. Stewart, E. Peen, R. Jonsson, and M.G. Humphreys-Beher. Transfer of human serum IgG into nonobese diabeticIggno 5mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren’s syndrome. Proc Natl Acad Sci. 95:7538(1998).
S. Bacman, L. Sterin-Borda, J. Jose Camusso, R. Arana, O. Hubscher, and E. Borda. Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren’s syndrome. Clin Exp Immunol. 104:454(1996).
S.A. Waterman, T..P Gordon, and M. Rischmueller. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren’s syndrome. Arthritis Rheum 43:1647(2000).
I. Saito, H. Kumiko, M. Shimuta, H. Inoue, H. Sakurai, K. Yamada, N. Ishimaru, H. Higashiyama, T. Sumida, H. Ishida, T. Suda, T. Noda, Y. Hayashi, and K. Tsubota. Fas ligand-mediated exocrinopathy resembling Sjögren’s syndrome in mice transgenic for IL-10.J Immunol.162:2488(1999).
B. Balasa, and N. Sarvetnick. The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes. J Autoimmun. 9:283(1996).
M.E. Pauza, H. Neal, A. Hagenbaugh, H. Cheroutre, and D. Lo. T-cell production of an inducible interleukin-10 transgene provides limited protection from autoimmune diabetes.Diabetes.;48:1948 (1999).
S.C. Pflugfelder, D. Jones, Z. Ji, A. Afonso, and D. Monroy. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren’s syndrome keratoconjunctivitis sicca. Curr. Eye Res.;19:201(1999).
D.T. Jones, D. Monroy, Z. Ji, and S.C. Pflugfelder. Alterations in ocular gene expression in Sjögren’s syndrome. Adv Exp Bio Med. 438:544(1998).
A.J. Wu, R.M. Lafrenie, C. Park, W. Apinhasmit, Z.J. Chen, H. Birkedal-Hansen, K.M. Yamada, W.G. Stetler-Stevenson, and B.J. Baum. Modulation of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) by interferon-y in a human salivary cell line. J Cell Physiol. 171:117(1997).
A.J. Wu, R.H. Kurrasch, J. Katz, P.C. Fox, B.J. Baum, and J.C. Atkinson. Effect of tumor necrosis factor-ct and interferon-y on the growth of a human salivary gland cell line. J Cell Physiol. 161:217(1994).
A.J. Wu, Z.J. Chen, B.J. Baum, and I.S. Ambudkar. Interferon-y induces persistent depletion of internal Cat’ stores in a cultured human salivary gland cell line. Am J Physiol. 270:C514(1996).
B. Balasa, and N. Sarvetnick. Is pathogenic humoral autoimmunity a Thl response? Lessons from (for) myasthenia gravis. Immunol Today. 21:19(2000).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic/Plenum Publishers
About this chapter
Cite this chapter
Humphreys-Beher, M.G., Brayer, J., Cha, S., Nagashima, H., Diggs, S., Peck, A.B. (2002). Immunogenetics of Autoimmune Exocrinopathy in the Nod Mouse: More Than Meets the Eye. In: Sullivan, D.A., Stern, M.E., Tsubota, K., Dartt, D.A., Sullivan, R.M., Bromberg, B.B. (eds) Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3. Advances in Experimental Medicine and Biology, vol 506. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0717-8_141
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0717-8_141
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5208-2
Online ISBN: 978-1-4615-0717-8
eBook Packages: Springer Book Archive